Source: Annual Congress 2009 - Pleural and parenchymal diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Tolokh, U. Chulovska, N. Rudnicka (Lviv, Ukraine). Treatment of sarcoidosis – pentoxifylline. Eur Respir J 2009; 34: Suppl. 53, 3531

Member's Comments

No comment yet.

Related content which might interest you: Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Eosinophilic pneumonia – Our own experience with diagnosis and treatment Source: Annual Congress 2012 - The good clinical practice: useful case report Year: 2012 Pulmonary TB -diabetes melitus – an unfavorable association Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Oral glucocorticoid treatment of severe asthma – Current practice in the US Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Surgical treatment of pulmonary sequestration – 15-years experience Source: Annual Congress 2010 - Congenital lesions and rare pathology Year: 2010 Chronic necrotizing aspergillosis – review of 10 cases Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Erdosteine – A new drug in the treatment of chronic rhinosinusitis Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Outcome of zinc & vit-A supplementation in the treatment multidrug resistance pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Asthma medication and antibiotics – Cause or effect? Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010 The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M3 Antagonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Cystic fibrosis: Heartburn and lung function – ²Too hot to handle² Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Tuberculoma of the lung – a report of 61 cases Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Clinical analysis of chronic hypersensitivity pneunonitis – Comparison with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Churg Strauss syndrome associated with montelukast treatment – Study case Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011 Tolerance of pirfenidone in Indian patients with idiopathic pulmonary fibrosis – Usual interstial pneumonitis: An initial experience Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011